SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Covalent Group Inc (CVGR) an undiscovered CRO

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JanyBlueEyes who wrote (82)10/20/1999 2:24:00 PM
From: JanyBlueEyes  Read Replies (1) of 107
 
Consolidated Statements of Operations
(all amounts in thousands, except per share amounts)
Unaudited

For the Three Months For the Nine Months
Ended September 30, Ended September 30,

1999 1998 1999 1998


Revenues $4,048 $2,709 $11,510 $7,492
Operating Expenses:
Direct 2,462 1,716 6,951 5,208
Selling and
Administrative 979 1,046 2,772 2,796
Income (Loss) from
Operations 607 (53) 1,787 (512)
Interest Income 42 21 91 78

Income (Loss) before
Income Taxes 649 (32) 1,878 (434)
Income Tax Provision
(Benefit) 240 (12) 695 (148)

Net Income (Loss) $409 $(20) $1,183
$(286)

Net Income (Loss) Per
Common Share
Basic and Diluted $.03 $.00 $.10
$(.02)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext